Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Ralph, Riello"'
Autor:
Matthew Griffin, Ralph Riello, Veena S. Rao, Juan Ivey-Miranda, James Fleming, Christopher Maulion, Wendy McCallum, Mark Sarnak, Sean Collins, Silvio E. Inzucchi, Jeffrey M. Testani
Publikováno v:
ESC Heart Failure, Vol 7, Iss 4, Pp 1966-1971 (2020)
Abstract Aims Diuretic resistance is common in acute decompensated heart failure (ADHF). When loop diuretic monotherapy is ineffective, thiazides are often recommended as adjunctive therapy, but these agents have many side effects and are associated
Externí odkaz:
https://doaj.org/article/81bc43908cc44acdb66b72b8d5086bbb
Autor:
Christopher Maulion, Veena S. Rao, Richard Soucier, Francine Lorusso, Devin Mahoney, Juan Betuel Ivey-Miranda, Margaret O’Brien, Jeffrey M. Testani, Prasama Sangkachand, Keith Churchwell, Lavanya Bellumkonda, F. Perry Wilson, Jennifer L. Asher, James Fleming, Jeffrey M. Turner, Ralph Riello, Julie D'Ambrosi, Sean P. Collins, Zachary L. Cox, Matthew D. Griffin
Publikováno v:
Journal of the American College of Cardiology. 77:695-708
Background Most acute decompensated heart failure admissions are driven by congestion. However, residual congestion is common and often driven by the lack of reliable tools to titrate diuretic therapy. The authors previously developed a natriuretic r
Autor:
Lavanya Bellumkonda, Sangchoon Jeon, Daniel Jacoby, Silvio E. Inzucchi, Juan Betuel Ivey-Miranda, Krishmita Siwakoti, Javed Butler, Zachary L. Cox, James Fleming, Jeffrey M. Turner, Christopher Maulion, Nisha Suda, Matthew D. Griffin, Tariq Ahmad, Ralph Riello, Devin Mahoney, Veena S. Rao, F. Perry Wilson, Jeffrey M. Testani, Sean P. Collins
Publikováno v:
Circulation. 142:1028-1039
Background: Sodium-glucose cotransporter-2 inhibitors improve heart failure–related outcomes. The mechanisms underlying these benefits are not well understood, but diuretic properties may contribute. Traditional diuretics such as furosemide induce
Autor:
Veena S. Rao, Matthew D. Griffin, Sean P. Collins, Wendy McCallum, Silvio E. Inzucchi, Juan Betuel Ivey-Miranda, Christopher Maulion, James Fleming, Mark J. Sarnak, Ralph Riello, Jeffrey M. Testani
Publikováno v:
ESC Heart Failure, Vol 7, Iss 4, Pp 1966-1971 (2020)
ESC Heart Failure
ESC Heart Failure
Aims Diuretic resistance is common in acute decompensated heart failure (ADHF). When loop diuretic monotherapy is ineffective, thiazides are often recommended as adjunctive therapy, but these agents have many side effects and are associated with wors
Autor:
W.H. Wilson Tang, Julie D'Ambrosi, Veena S. Rao, Jeffrey M. Testani, Matthew D. Griffin, Tariq Ahmad, Daniel Jacoby, Matthew Colna, Erden Goljo, P. Raghavendra, Sangchoon Jeon, Devin Mahoney, Wilfried Mullens, Jeffrey M. Turner, Francis P. Wilson, Michael Chen, Steven G. Coca, Aaron Soufer, Ralph Riello
Publikováno v:
Article
OBJECTIVES The purpose of this study was to investigate real world safety and efficacy of hypertonic saline therapy in cases of refractory acute decompensated heart failure (ADHF) at a large U.S. academic medical center. BACKGROUND Hypertonic saline
Autor:
Bertram Pitt, Ralph Riello
Publikováno v:
JACC: Heart Failure. 9:25-27
Autor:
Ronac Mamtani, Ralph Riello, James J. Harrigan, Erin Bange, Sunil Thomas, Mira Mamtani, Rebecca A. Hubbard
Publikováno v:
Journal of General Internal Medicine
Autor:
Mitchell A. Psotka, Megan McCullough, John R. Teerlink, JoAnn Lindenfeld, Ralph Riello, P. Elliott Miller, Michael Böhm, Nihar R. Desai, Larry A. Allen, Giuseppe M.C. Rosano, Tariq Ahmad
Publikováno v:
European Journal of Heart Failure
European journal of heart failure, vol 21, iss 9
European journal of heart failure, vol 21, iss 9
Current pharmacological therapies for heart failure with reduced ejection fraction are largely either repurposed anti-hypertensives that blunt overactivation of the neurohormonal system or diuretics that decrease congestion. However, they do not addr
Publikováno v:
European Cardiology Review, Vol 16, Iss, Pp-(2021)
European Cardiology Review
European Cardiology Review
Patients with type 2 diabetes are at increased cardiovascular risk. Until recently, reductions in HbA1c and the use of specific glucose-lowering agents have not had a clear, reproducible benefit in reducing the incidence of cardiovascular disease. Ho
Autor:
John R. Teerlink, Ralph Riello, Mitchell A. Psotka, Tariq Ahmad, JoAnn Lindenfeld, John-Ross D. Clarke, Nihar R. Desai, Larry A. Allen
Publikováno v:
Circulation. Heart failure. 14(2)
Background: A growing population of patients with end-stage heart failure (HF) with reduced ejection fraction has limited treatment options to improve their quality and quantity of life. Although positive inotropes have failed to show survival benefi